"Located in Los Angeles, Huntington Park, and Panorama City, National Research Institute has provided free quality medical and quality care to patients with Diabetes and Fatty Liver and has performed clinical trials for over 30 years."

During the past decade, National Research Institute conducted 105 clinical trials. In the 10-year time frame, 105 clinical trials started and 74 clinical trials were completed, i.e. on average, 70.5% percent of trials that started reached the finish line to date. In the past 5 years, 54 clinical trials started and 49 clinical trials were completed. i.e. 90.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National Research Institute" #1 sponsor was "Pfizer" with 22 trials, followed by "Eli Lilly and Company" with 19 trials sponsored, "Boehringer Ingelheim" with 8 trials sponsored, "AstraZeneca" with 5 trials sponsored and "Gilead Sciences" with 5 trials sponsored. Other sponsors include 78 different institutions and companies that sponsored additional 63 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Research Institute" #1 collaborator was "Integrium" with 3 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator and "ICON Clinical Research" with 2 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "National Research Institute" are "Type 2 Diabetes Mellitus" (24 trials), "Diabetes Mellitus, Type 2" (11 trials), "Type 2 Diabetes" (11 trials), "Hypertension" (10 trials) and "Migraine" (8 trials). Many other conditions were trialed in "National Research Institute" in a lesser frequency.

Most popular intervention types in "National Research Institute" are "Drug" (131 trials), "Other" (8 trials), "Biological" (4 trials), "Device" (4 trials) and "Behavioral" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (77 trials), "Tirzepatide" (9 trials), "Metformin" (7 trials), "placebo" (6 trials) and "Dapagliflozin" (5 trials). Other intervention names were less common.

The vast majority of trials in "National Research Institute" are 135 trials for "All" genders and 7 trials for "Female" genders.

Currently, there are NaN active trials in "National Research Institute". undefined are not yet recruiting, 15 are recruiting, 11 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 105 completed trials in National Research Institute, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in National Research Institute, 2 "Phase 1" clinical trials were conducted, 73 "Phase 2" clinical trials and 58 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 3 trials that are defined as “Not Applicable".